<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: <z:hpo ids='HP_0002725'>Systemic lupus erythematosus</z:hpo> is a multi-organ <z:e sem="disease" ids="C0004364" disease_type="Disease or Syndrome" abbrv="">autoimmune disorder</z:e> associated with autoantibodies of complex diversity </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> (aPL), which are commonly associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>, create a pro-thrombotic tendency, but are also associated with non-thrombotic neurological features </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0100022'>Movement disorders</z:hpo> are rare neuropsychiatric complications of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, and autoimmune and <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo> mechanisms have been proposed </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: We describe the clinical features, investigation findings, treatment, and outcome of six paediatric participants with <z:hpo ids='HP_0100022'>movement disorders</z:hpo> associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> and/or aPL (six females, median age 13 y, range 8-15) </plain></SENT>
<SENT sid="4" pm="."><plain>To examine the autoantibody hypothesis, we used a neuronal cell line with dopaminergic characteristics and measured serum antibody binding to neuronal cell-surface antigens using flow cytometry </plain></SENT>
<SENT sid="5" pm="."><plain>For comparison with the six participants, we used serum from healthy individuals (n=12, six females, median age 11 y, range 9-13) and children with other <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e> (n=13, seven females, median age 7 y, range 2-15) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Of the six participants, two had <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> only, two had <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> with aPL, and two had aPL only </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:hpo ids='HP_0100022'>movement disorder</z:hpo> was <z:hpo ids='HP_0002072'>chorea</z:hpo> in four and <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> in two </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> four participants with <z:hpo ids='HP_0002072'>chorea</z:hpo> had aPL and <z:hpo ids='HP_0100022'>movement disorder</z:hpo> relapses </plain></SENT>
<SENT sid="9" pm="."><plain>The two participants with <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> did not have aPL, but had a progressive course until rituximab or plasma exchange resulted in neuropsychiatric remission </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> six participants demonstrated elevated serum antibody binding to neuronal cell-surface antigens compared with healthy individuals and those with other <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological diseases</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>INTERPRETATION: This report supports the association of <z:hpo ids='HP_0002072'>chorea</z:hpo> with aPL, but suggests a different autoimmune mechanism operates in <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0001300'>parkinsonism</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>The presence of antibody binding to neuronal cell-surface antigens supports a possible direct action of autoantibodies on neurons in patients with <z:hpo ids='HP_0100022'>movement disorders</z:hpo> associated with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> and aPL </plain></SENT>
</text></document>